Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    November 2022
  1. GAGNON C
    Reduced Intestinal Calcium Absorption Correlates with Bone Loss After Sleeve Gastrectomy: Implications for Clinical Care.
    J Clin Endocrinol Metab. 2022 Nov 24:dgac681. doi: 10.1210.
    PubMed    


  2. MESSNER Z, Carro-Vazquez D, Haschka J, Grillari J, et al
    Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis.
    J Clin Endocrinol Metab. 2022 Nov 19:dgac667. doi: 10.1210.
    PubMed     Abstract available


  3. WU CH, Li CC, Hsu YH, Liang FW, et al
    Comparisons between different anti-osteoporosis medications on postfracture mortality: A population-based study.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785916. doi: 10.1210.
    PubMed     Abstract available


    October 2022
  4. KLINE GA, Morin SN, Lix LM, McCloskey EV, et al
    General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study.
    J Clin Endocrinol Metab. 2022 Oct 6. pii: 6750025. doi: 10.1210.
    PubMed     Abstract available


    September 2022
  5. REID IR
    How Often Should We Measure Bone Density?
    J Clin Endocrinol Metab. 2022;107:e4267-e4268.
    PubMed    


  6. FAN W, Machado M, Leder BZ, Beyer L, et al
    Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691222. doi: 10.1210.
    PubMed     Abstract available


  7. LI I, Hartley IR, Klubo-Gwiedzdzinska J, Reynolds JC, et al
    Fracture Risk in Pediatric Patients with MEN2B.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691128. doi: 10.1210.
    PubMed     Abstract available


    August 2022
  8. SINGH S, Morshed S, Motamedi D, Kidane J, et al
    Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty.
    J Clin Endocrinol Metab. 2022;107:e3944-e3952.
    PubMed     Abstract available


  9. MATSUMOTO T, Sone T, Soen S, Tanaka S, et al
    Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study.
    J Clin Endocrinol Metab. 2022 Aug 17. pii: 6670847. doi: 10.1210.
    PubMed     Abstract available


    July 2022
  10. LYU H, Zhao S, Li J, Li X, et al
    Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:e3366-e3373.
    PubMed     Abstract available


    June 2022
  11. OHEIM R, Tsourdi E, Seefried L, Beller G, et al
    Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    J Clin Endocrinol Metab. 2022;107:e3048-e3057.
    PubMed     Abstract available


    May 2022
  12. ENSRUD KE, Lui LY, Crandall CJ, Orwoll ES, et al
    Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6589466. doi: 10.1210.
    PubMed     Abstract available


  13. COMNINOS AN, Hansen MS, Courtney A, Choudhury S, et al
    Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
    J Clin Endocrinol Metab. 2022;107:1529-1540.
    PubMed     Abstract available


  14. CIUFFI S, Marini F, Fossi C, Donati S, et al
    Circulating microRNAs as biomarkers of osteoporosis and fragility fractures.
    J Clin Endocrinol Metab. 2022 May 9. pii: 6582745. doi: 10.1210.
    PubMed     Abstract available


  15. CARWILE JL, Seshasayee SM, Ahrens KA, Hauser R, et al
    Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
    J Clin Endocrinol Metab. 2022 May 3. pii: 6575101. doi: 10.1210.
    PubMed     Abstract available


    April 2022
  16. AGARWAL S, Shane E, Lang T, Shiau S, et al
    Spine volumetric BMD and strength in premenopausal idiopathic osteoporosis: Effects of teriparatide followed by denosumab.
    J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569192. doi: 10.1210.
    PubMed     Abstract available


  17. YOO JE, Yoon JW, Park HE, Han K, et al
    Response to Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563352. doi: 10.1210.
    PubMed    


  18. ZHOU Q
    Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563351. doi: 10.1210.
    PubMed    


    March 2022
  19. FRARA S, Uygur MM, di Filippo L, Doga M, et al
    High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.
    J Clin Endocrinol Metab. 2022 Mar 29. pii: 6555665. doi: 10.1210.
    PubMed     Abstract available


  20. BORN C, Jakob F, Shojaa M, Kohl M, et al
    Effects of hormone therapy and exercise on bone mineral density in healthy women - A systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553368. doi: 10.1210.
    PubMed     Abstract available


  21. PENA DIAS J, Piggott DA, Sun J, Wehbeh L, et al
    SHBG, bone mineral density and physical function among injection drug users with and without HIV and HCV.
    J Clin Endocrinol Metab. 2022 Mar 16. pii: 6549479. doi: 10.1210.
    PubMed     Abstract available


    February 2022
  22. BALEANU F, Moreau M, Charles A, Iconaru L, et al
    Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.
    J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530319. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  23. COLL JC, Garceau E, Leslie WD, Genest M, et al
    Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).
    J Clin Endocrinol Metab. 2022 Jan 28. pii: 6517001. doi: 10.1210.
    PubMed     Abstract available


  24. KLINE GA, Morin SN, Lix LM, Leslie WD, et al
    Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:491-499.
    PubMed     Abstract available


    December 2021
  25. QUESTER J, Nethander M, Eriksson A, Ohlsson C, et al
    Endogenous DHEAS is Causally Linked with Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
    J Clin Endocrinol Metab. 2021 Dec 22. pii: 6479181. doi: 10.1210.
    PubMed     Abstract available


  26. COSENTINI D, Grisanti S, Hadoux J, Libe R, et al
    Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461116. doi: 10.1210.
    PubMed     Abstract available


  27. WANG B, Wang Z, Poundarik AA, Zaki MJ, et al
    Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.
    J Clin Endocrinol Metab. 2021 Dec 9. pii: 6458464. doi: 10.1210.
    PubMed     Abstract available


    November 2021
  28. YOO JE, Yoon JW, Park HE, Han K, et al
    Blood pressure variability and the risk of fracture: a nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Nov 28. pii: 6445180. doi: 10.1210.
    PubMed     Abstract available


  29. SHANE E, Shiau S, Recker RR, Lappe JM, et al
    Denosumab After Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2021 Nov 24. pii: 6437931. doi: 10.1210.
    PubMed     Abstract available


  30. DAWOOD NB, Tseng CH, Nguyen DT, Yan KL, et al
    Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    J Clin Endocrinol Metab. 2021;106:e4993-e5000.
    PubMed     Abstract available


    October 2021

  31. Corrigendum to: Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410701. doi: 10.1210.
    PubMed    


    September 2021
  32. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    PubMed    


  33. SHIEH A, Ruppert KM, Greendale GA, Lian Y, et al
    Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women.
    J Clin Endocrinol Metab. 2021 Sep 19. pii: 6372418. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  34. VIOLA V, Tramontana F, Leanza G
    Letter to the Editor from Viola Viola: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis".
    J Clin Endocrinol Metab. 2021 Aug 14. pii: 6352412. doi: 10.1210.
    PubMed    


  35. KARAKILIC E, Saygili ES
    Letter to the Editor From Karakilic and Saygili:" Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes".
    J Clin Endocrinol Metab. 2021 Aug 13. pii: 6350455. doi: 10.1210.
    PubMed    


  36. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Response letter to the Editor from Dr. Viola et al. "Diminishing value from multiple serial bone densitometry in women receiving antiresorptive medication for osteoporosis."
    J Clin Endocrinol Metab. 2021 Aug 7. pii: 6345421. doi: 10.1210.
    PubMed    


  37. CROMER SJ, Yu EW
    Challenges and opportunities for osteoporosis care during the COVID-19 pandemic.
    J Clin Endocrinol Metab. 2021 Aug 3. pii: 6337853. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  38. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  39. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
    Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
    J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
    PubMed     Abstract available


  40. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
    Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
    PubMed     Abstract available


  41. WARD LM, Ma J, Robinson ME, Scharke M, et al
    Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
    J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
    PubMed     Abstract available


  42. WARD LM, Choudhury A, Alos N, Cabral DA, et al
    Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
    J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
    PubMed     Abstract available


  43. LING CW, Miao Z, Xiao ML, Zhou H, et al
    The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
    PubMed     Abstract available


  44. MITCHELL A, Fall T, Melhus H, Lind L, et al
    Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  45. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  46. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  47. CHAPURLAT R
    Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
    J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
    PubMed    


    May 2021
  48. KIM JA, Lee JS, Song E, Roh E, et al
    Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
    PubMed     Abstract available


  49. ZAWORSKI C, Cheah J, Koff MF, Breighner R, et al
    MRI-based texture analysis of trabecular bone for opportunistic screening of skeletal fragility.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6276953. doi: 10.1210.
    PubMed     Abstract available


  50. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    PubMed     Abstract available


  51. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    PubMed    



  52. Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    PubMed    


    April 2021
  53. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    PubMed     Abstract available


  54. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  55. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    PubMed     Abstract available


  56. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    PubMed     Abstract available


  57. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available


  58. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    PubMed     Abstract available


  59. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    PubMed     Abstract available


  60. GONG R, Xiao HM, Zhang YH, Zhao Q, et al
    Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161511. doi: 10.1210.
    PubMed     Abstract available


    February 2021

  61. Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    PubMed    


  62. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    PubMed     Abstract available


  63. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    PubMed     Abstract available


  64. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  65. KONG SH, Kim JH, Shin CS
    Serum Spermidine as a Novel Potential Predictor for Fragility Fractures.
    J Clin Endocrinol Metab. 2021;106:e582-e591.
    PubMed     Abstract available


  66. MISRA M, Bredella MA
    Bone Metabolism in Adolescents Undergoing Bariatric Surgery.
    J Clin Endocrinol Metab. 2021;106:326-336.
    PubMed     Abstract available


  67. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    PubMed    


  68. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    PubMed     Abstract available



  69. Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    PubMed    


  70. HANNEMANN A, Nauck M, Volzke H, Weidner H, et al
    Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
    J Clin Endocrinol Metab. 2021;106:e288-e299.
    PubMed     Abstract available


    November 2020
  71. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    PubMed     Abstract available


  72. BROADWELL A, Chines A, Ebeling PR, Franek E, et al
    Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2020 Nov 19. pii: 5992310. doi: 10.1210.
    PubMed     Abstract available


  73. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    PubMed     Abstract available


  74. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  75. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    PubMed     Abstract available


  76. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    PubMed     Abstract available


    September 2020
  77. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  78. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    April 2020
  79. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  80. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  81. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    December 2019
  82. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: